Precision BioSciences shareholders approve increase of 630,000 shares in incentive plan

PRECISION BIOSCIENCES INC

Shareholders elected Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. as Class II directors for term until 2027.
Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 5,162,463 votes for.
Amendment to 2019 Incentive Award Plan approved, increasing share reserve by 630,000 shares; 2,597,767 for, 836,298 against.
Adjournment proposal approved with 2,649,161 votes for, if needed to solicit additional proxies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.